🐜
|
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
19 auth.
M. Bassani-Sternberg,
E. Bräunlein,
R. Klar,
T. Engleitner,
Pavel Sinitcyn,
S. Audehm,
M. Straub,
J. Weber,
J. Slotta-Huspenina,
K. Specht,
...
M. Martignoni,
A. Werner,
R. Hein,
Dirk H. Busch,
C. Peschel,
R. Rad,
J. Cox,
M. Mann,
A. Krackhardt
|
9 |
2016 |
9 🐜
|
🐜
|
Noninvasive Visualization of the Activated αvβ3 Integrin in Cancer Patients by Positron Emission Tomography and [18F]Galacto-RGD
12 auth.
R. Haubner,
W. Weber,
A. Beer,
E. Vabuliene,
D. Reim,
M. Sarbia,
...
K. Becker,
Michael Goebel,
R. Hein,
H. Wester,
H. Kessler,
M. Schwaiger
|
8 |
2005 |
8 🐜
|
🐜
|
The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network
36 auth.
C. Voskens,
S. Goldinger,
C. Loquai,
C. Robert,
K. Kaehler,
C. Berking,
T. Bergmann,
C. Bockmeyer,
T. Eigentler,
M. Fluck,
C. Garbe,
R. Gutzmer,
S. Grabbe,
A. Hauschild,
R. Hein,
...
G. Hundorfean,
Armin Justich,
U. Keller,
C. Klein,
C. Mateus,
P. Mohr,
S. Paetzold,
I. Satzger,
D. Schadendorf,
M. Schlaeppi,
G. Schuler,
B. Schuler-Thurner,
U. Trefzer,
J. Ulrich,
Julia Vaubel,
R. von Moos,
P. Weder,
T. Wilhelm,
D. Göppner,
R. Dummer,
L. Heinzerling
|
8 |
2013 |
8 🐜
|
🐜
|
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement
47 auth.
N. Hunzelmann,
E. Genth,
T. Krieg,
W. Lehmacher,
I. Melchers,
M. Meurer,
P. Moinzadeh,
U. Müller-Ladner,
C. Pfeiffer,
G. Riemekasten,
E. Schulze-Lohoff,
C. Sunderkoetter,
Manfred Weber,
M. Worm,
P. Klaus,
...
A. Rubbert,
K. Steinbrink,
B. Grundt,
R. Hein,
K. Scharffetter-Kochanek,
R. Hinrichs,
K. M. Walker,
R. Szeimies,
S. Karrer,
A. Müller,
C. Seitz,
E. Schmidt,
P. Lehmann,
I. Foeldvari,
F. Reichenberger,
W. Gross,
A. Kuhn,
M. Haust,
K. Reich,
M. Böhm,
P. Saar,
G. Fierlbeck,
I. Kötter,
H. Lorenz,
N. Blank,
K. Gräfenstein,
A. Juche,
E. Aberer,
G. Bali,
C. Fiehn,
R. Stadler,
V. Bartels
|
8 |
2008 |
8 🐜
|
🐜
|
Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis.
10 auth.
S. Plötz,
H. Simon,
U. Darsow,
D. Simon,
E. Vassina,
S. Yousefi,
...
R. Hein,
Tim A. Smith,
H. Behrendt,
J. Ring
|
7 |
2003 |
7 🐜
|
🐜
|
Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma.
8 auth.
A. Bosserhoff,
M. Kaufmann,
B. Kaluza,
I. Bartke,
H. Zirngibl,
R. Hein,
...
Wilhelm Stolz,
R. Buettner
|
7 |
1997 |
7 🐜
|
🐜
|
Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical features
25 auth.
R. Mierau,
P. Moinzadeh,
G. Riemekasten,
I. Melchers,
M. Meurer,
F. Reichenberger,
M. Buslau,
M. Worm,
N. Blank,
R. Hein,
U. Müller-Ladner,
A. Kuhn,
C. Sunderkötter,
A. Juche,
C. Pfeiffer,
...
C. Fiehn,
M. Sticherling,
P. Lehmann,
R. Stadler,
E. Schulze-Lohoff,
C. Seitz,
I. Foeldvari,
T. Krieg,
E. Genth,
N. Hunzelmann
|
7 |
2011 |
7 🐜
|
🐜
|
Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels.
12 auth.
B. Belloni,
M. Ziai,
A. Lim,
B. Lemercier,
M. Sbornik,
S. Weidinger,
...
C. Andres,
C. Schnopp,
J. Ring,
R. Hein,
M. Ollert,
M. Mempel
|
7 |
2007 |
7 🐜
|
🐜
|
Neoadjuvant Imatinib in Advanced Primary or Locally Recurrent Dermatofibrosarcoma Protuberans: A Multicenter Phase II DeCOG Trial with Long-term Follow-up
15 auth.
S. Ugurel,
T. Mentzel,
J. Utikal,
P. Helmbold,
P. Mohr,
C. Pföhler,
M. Schiller,
A. Hauschild,
R. Hein,
E. Kämpgen,
...
I. Kellner,
M. Leverkus,
J. Becker,
P. Ströbel,
D. Schadendorf
|
6 |
2013 |
6 🐜
|
🐬
|
Once‐daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double‐blind, placebo‐controlled study
J. Ring,
R. Hein,
A. Gauger,
E. Bronsky,
B. Miller
|
6 |
2001 |
6 🐬
|
🐢
|
Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid.
A. Kasche,
S. Luderschmidt,
J. Ring,
R. Hein
|
6 |
2006 |
6 🐢
|